Literature DB >> 23948310

Quantitative online isolation of ⁶⁸Ge from ⁶⁸Ge/⁶⁸Ga generator eluates for purification and immediate quality control of breakthrough.

Elisabeth Eppard1, Natalia S Loktionova, Frank Rösch.   

Abstract

The breakthrough of ⁶⁸Ge from a ⁶⁸Ge/⁶⁸Ga-generator is one of the most sensitive parameters in the context of the clinical application of ⁶⁸Ga-radiopharmaceuticals. The difficulty in its determination lies in the "spectroscopic invisibility" of ⁶⁸Ge within an excess of ⁶⁸Ga. The introduced method for determining the ⁶⁸Ge content of the ⁶⁸Ge/⁶⁸Ga-generator eluate involves the quantitative separation of ⁶⁸Ga from ⁶⁸Ge, using a cation-exchanger. The eluate contains ⁶⁸Ga free of ⁶⁸Ge, which can be determined immediately, i.e. prior to the application of the ⁶⁸Ga-radiopharmaceutical.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  Breakthrough; Ga-68; Ge-68; Generator; Separation

Mesh:

Substances:

Year:  2013        PMID: 23948310     DOI: 10.1016/j.apradiso.2013.07.020

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

Review 1.  Translating a radiolabeled imaging agent to the clinic.

Authors:  Gary L Griffiths; Crystal Vasquez; Freddy Escorcia; Jeff Clanton; Liza Lindenberg; Esther Mena; Peter L Choyke
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

2.  Production and separation of 43Sc for radiopharmaceutical purposes.

Authors:  Katharina A Domnanich; Robert Eichler; Cristina Müller; Sara Jordi; Vera Yakusheva; Saverio Braccini; Martin Behe; Roger Schibli; Andreas Türler; Nicholas P van der Meulen
Journal:  EJNMMI Radiopharm Chem       Date:  2017-11-25

3.  Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy.

Authors:  Ferdinand Sudbrock; Thomas Fischer; Beate Zimmermanns; Mehrab Guliyev; Markus Dietlein; Alexander Drzezga; Klaus Schomäcker
Journal:  EJNMMI Res       Date:  2014-07-24       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.